3324 NCCTG N0879 (Alliance): A randomized phase II cooperative group trial of carboplatin, paclitaxel, bevacizumab, =/- everolimus (CPB+/-E) for metastatic melanoma. (September 2015) - McWilliams, R.R.; Allred, J.; Kottschade, L.; Erickson, L.; Katipamula, R.; Gupta, M.; Dronca, R.; Rumilla, K.; Markovic, S.